skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma

Patent ·
OSTI ID:1531460

A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.

Research Organization:
Univ. of Missouri, Columbia, MO (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
FG02-93ER61661
Assignee:
The Curators of the University of Missouri (Columbia, MO)
Patent Number(s):
6,607,709
Application Number:
09/686,700
OSTI ID:
1531460
Resource Relation:
Patent File Date: 2000-10-11
Country of Publication:
United States
Language:
English

References (37)

Novel metal-binding proteins by design journal May 1995
[111In]-DTPA-labeled analogues of α-melanocyte-stimulating hormone for melanoma targeting: Receptor bindingin vitro andin vivo journal September 1994
The Design of Metal-Binding Sites in Proteins journal June 1993
Tissue sulfhydryl groups journal May 1959
Synthesis and copper(II)-binding properties of the N-terminal peptide of human α-fetoprotein journal February 1989
Fluorine-18-labeled [Nle4,d-Phe7]-α-MSH, an α-melanocyte stimulating hormone analogue journal February 1997
Complexes of technetium-99m with tetrapeptides, a new class of 99mTc-labelled agents journal April 1995
Design, Synthesis, and Conformation of Superpotent and Prolonged Acting Melanotropins journal May 1993
Rhenium(V) oxo complexes relevant to technetium renal imaging agents derived from mercaptoacetylglycylglycylaminobenzoic acid isomers. Structural and molecular mechanics studies journal June 1992
Restart procedures for the conjugate gradient method journal December 1977
Homodimeric and Heterodimeric Bis(amino thiol) Oxometal Complexes with Rhenium(V) and Technetium(V). Control of Heterodimeric Complex Formation and an Approach to Metal Complexes that Mimic Steroid Hormones journal April 1994
Molecular design to mimic the copper(II) transport site of human albumin: studies of equilibria between copper(II) and glycylglycyl- L -histidine- N -methyl amide and comparison with human albumin journal April 1976
The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanoma journal February 1992
Oxygen atom transfer among rhenium, sulfur, and phosphorus. Characterization and reactivity of Re(O)Cl3(Me2S)(OPPh3) and Re(O)Cl3(CNCMe3)2 journal July 1987
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. journal April 1993
Characterization of the Iron-binding Site in Mammalian Ferrochelatase by Kinetic and Mössbauer Methods journal November 1995
Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions journal November 1992
Synthesis, Characterization and Crystal Structures of Technetium(V)-Oxo Complexes Useful in Nuclear Medicine. 1. Complexes of Mercaptoacetylglycylglycylglycine (MAG3) and Its Methyl Ester Derivative (MAG3OMe) journal March 1995
Cyclic Melanotropins. 9. 7-D-Phenylalanine Analogues of the Active-Site Sequence journal May 1985
Protein Stabilization by Engineered Metal Chelation journal October 1991
Synthesis and Characterization of Rhenium-Complexed α-Melanotropin Analogs journal May 1997
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation journal January 1991
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. journal June 1988
Oxo-complexes of rhenium(V) journal January 1966
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. journal October 1980
In situ melanin assay for MSH using mouse B16 melanoma cells in culture journal November 1986
Radiolabeled peptides and other ligands for receptors overexpressed in tumor cells for imaging neoplasms journal August 1996
Radioreceptor Assay for α;-Msh Using Mouse B16 Melanoma Cells journal January 1988
Metalloantibodies journal August 1990
Technetium (V) and rhenium (V) complexes of 2,3-bis(mercaptoacetamido)propanoate. Chelate ring stereochemistry and influence on chemical and biological properties journal July 1990
Design and characterization of  -melanotropin peptide analogs cyclized through rhenium and technetium metal coordination journal October 1998
Influence of α-MSH terminal amino acids on binding affinity and biological activity in melanoma cells journal January 1994
Structure proof of syn/anti isomerism in N-alkylated diaminedithiol (DADT) complexes of technetium journal October 1990
Recent Developments in Peptide Drug Delivery to the Brain journal July 1992
Synthetic analogues of .alpha.-melanotropin patent November 1984
Stability and Conformational Analysis of Tc-RC160 and Re-RC160:  Experimental and Theoretical Analysis of the Influence of Metal Complexation on the Structural Requisites for Activity journal January 1996
A chelating derivative of α-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma journal December 1990

Cited By (7)

Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same patent August 2018
Metal abstraction peptide with superoxide dismutase activity patent November 2015
Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targeting patent October 2016
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same patent March 2015
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same patent November 2016
Metal abstraction peptide (MAP) tag and associated methods patent August 2015
Metal abstraction peptide (MAP) tag and associated methods patent March 2015

Similar Records